Best treatments for prostatic neoplasms (prostate cancer)

Understanding prostatic neoplasms

Prostate cancer begins in the cells of the prostate, a gland in the male reproductive system that lies just below the bladder and in front of the rectum, surrounds part of the urethra, and makes fluid that is part of semen (NCI; MedlinePlus). In the United States, about one out of eight men will be diagnosed with prostate cancer, and it often grows very slowly (NCI; MedlinePlus). Early prostate cancer usually does not cause symptoms. When symptoms occur, they can include a weak, interrupted, or hard-to-start urine stream, frequent urination (especially at night), or trouble emptying the bladder; more advanced disease may cause blood in the urine or semen or persistent pain in the back, hips, or pelvis (NCI; MedlinePlus). Diagnosis may involve a digital rectal exam and a PSA blood test, but a biopsy is the only way to confirm prostate cancer; the biopsy also establishes the grade (Gleason score/Grade Group) (NCI; MedlinePlus). Findings are combined into a stage. Management ranges from watchful waiting or active surveillance to active treatment, guided by the cancer's characteristics and the person's health. This is general information, not medical advice.

Frequently asked

What is the best medication for prostate cancer?

prostate cancer is prostatic neoplasms. There isn't a single "best" medication for everyone — There is no single treatment that is best for everyone; in many cases no one option is clearly better than the others, and it can help to get more than one opinion, including from different types of specialists (ACS). Treatment selection depends on the stage of the cancer, the PSA level, the Gleason score/Grade Group, whether the cancer has spread, the person's age and overall health, life expectancy, and personal preferences about possible side effects (NCI; ACS). Because early prostate cancer often grows slowly, categories of standard options include watchful waiting or active surveillance, surgery (radical prostatectomy), radiation therapy, hormone therapy, chemotherapy, targeted therapy, and immunotherapy (NCI; ACS). The specific plan — including whether to treat immediately or monitor — is individualized for each patient and should be decided with a qualified oncology care team. This is general information, not medical advice.. Compare every option ranked above by our independent recall-safety rating (not an efficacy measure); this is general information, not medical advice.

What treats prostatic neoplasms?

Our catalog lists 29 products that may treat prostatic neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is elestrin.

What is the best-rated treatment for prostatic neoplasms?

By our independent recall-safety rating — not an efficacy measure — elestrin ranks highest among the products we list for prostatic neoplasms. Always consult a professional.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

What types of drugs treat prostatic neoplasms?

Treatments for prostatic neoplasms span FDA drug classes including estrogen, 5-alpha reductase inhibitor, androgen receptor inhibitor, topoisomerase inhibitor, gonadotropin releasing hormone receptor antagonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.